1 CagriSema 2.4 mg 2.4 mg FDA NDA filing; Novo Nordisk data on file., 2 Garvey WT, Blher M, Osorto Contreras CK, et al. Coadministered cagrilintide and semaglutide in adults with overweight or Novo Nordisk says compounded drugs are hurting Wegovy sales CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Ever heard of Cagrilintide? Its a peptide thats been making waves for helping with weight loss. , It works by reducing your appetite and helping your body burn fat more efficiently. If youre Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica